![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Environmental and Molecular Toxicology, North Carolina State University, Raleigh, North Carolina
The Polycyclic Aromatic Hydrocarbon Naphthalene Is An Environmental Pollutant, A Component Of Jet Fuel, And, Since 2000, Has Been Reclassified As A Potential Human Carcinogen. Few Studies Of The In Vitro Human Metabolism Of Naphthalene Are Available, And These Focus Primarily On Lung Metabolism. The Current Studies Were Performed To Characterize Naphthalene Metabolism By Human Cytochromes P450. Naphthalene Metabolites From Pooled Human Liver Microsomes (Phlms) Were Trans-1,2-Dihydro-1,2-Naphthalenediol (Dihydrodiol), 1-Naphthol, And 2-Naphthol. Metabolite Production Generated KM Values Of 23, 40, And 116 µM And VMax Values Of 2860, 268, And 22 Pmol/Mg Protein/Min, Respectively. P450 Isoform Screening Of Naphthalene Metabolism Identified Cyp1A2 As The Most Efficient Isoform For Producing Dihydrodiol And 1-Naphthol, And Cyp3A4 As The Most Effective For 2-Naphthol Production. Metabolism Of The Primary Metabolites Of Naphthalene Was Also Studied To Identify Secondary Metabolites. Whereas 2-Naphthol Was Readily Metabolized By Phlms To Produce 2,6- And 1,7-Dihydroxynaphthalene, Dihydrodiol And 1-Naphthol Were Inefficient Substrates For Phlms. A Series Of Human P450 Isoforms Was Used To Further Explore The Metabolism Of Dihydrodiol And 1-Naphthol. 1,4-Naphthoquinone And Four Minor Unknown Metabolites From 1-Naphthol Were Observed, And Cyp1A2 And 2D6*1 Were Identified As The Most Active Isoforms For The Production Of 1,4-Naphthoquinone. Dihydrodiol Was Metabolized By P450 Isoforms To Three Minor Unidentified Metabolites With Cyp3A4 And Cyp2A6 Having The Greatest Activity Toward This Substrate. The Metabolism Of Dihydrodiol By P450 Isoforms Was Lower Than That Of 1-Naphthol. These Studies Identify Primary And Secondary Metabolites Of Naphthalene Produced By Phlms And P450 Isoforms.
This article has been cited by other articles:
![]() |
G. I. Somers, N. Lindsay, B. M. Lowdon, A. E. Jones, C. Freathy, S. Ho, A. J. M. Woodrooffe, M. K. Bayliss, and G. R. Manchee A Comparison of the Expression and Metabolizing Activities of Phase I and II Enzymes in Freshly Isolated Human Lung Parenchymal Cells and Cryopreserved Human Hepatocytes Drug Metab. Dispos., October 1, 2007; 35(10): 1797 - 1805. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Usmani, T. M. Cho, R. L. Rose, and E. Hodgson Inhibition of the Human Liver Microsomal and Human Cytochrome P450 1A2 and 3A4 Metabolism of Estradiol by Deployment-Related and Other Chemicals Drug Metab. Dispos., September 1, 2006; 34(9): 1606 - 1614. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-L. Wu, C. D. Sohl, T. Shimada, and F. P. Guengerich Recombinant Enzymes Overexpressed in Bacteria Show Broad Catalytic Specificity of Human Cytochrome P450 2W1 and Limited Activity of Human Cytochrome P450 2S1 Mol. Pharmacol., June 1, 2006; 69(6): 2007 - 2014. [Abstract] [Full Text] [PDF] |
||||